LAMIVUDINE and ZIDOVUDINE

Product NDC
31722-506
11-digit product format
317220506
Labeler code
31722
Product ID
31722-506_e8ca069d-b3f8-35bf-e053-2a95a90a0699
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
LAMIVUDINE and ZIDOVUDINE
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
Camber Pharmaceuticals, Inc.
Application
ANDA079124
Marketing category
ANDA
Marketing start
2015-09-18
Substance
LAMIVUDINE; ZIDOVUDINE
Active strength
150; 300 mg/1; mg/1
Pharmacologic classes
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
LAMIVUDINE and ZIDOVUDINE
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
LAMIVUDINE150 mg/1
ZIDOVUDINE300 mg/1

Harmonized Identifiers#

Field, Values table
FieldValues
Unii2T8Q726O95, 4B9XT59T7S
Rxcui200082

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
aaa99659-c62c-7281-d402-9590409850c2Product name620260128
a02e6d35-8cc4-a80a-fd4d-d3ec16f69b8eProduct name820250626
4ef90d80-1289-4267-a2bb-01c741d1208fProduct name120230829
72dcca4e-6eae-4149-a92b-264c2a07004fProduct name120230808
3832141c-c294-474a-9473-1052c891450eProduct name220230105
320f244d-8b4e-4893-9f14-104b2a8e0aafProduct name220201007
7ff71f22-5b66-4a3d-bf64-671893a6409dProduct name220201007
3644e9cf-6f4d-4b63-b875-6a4b5187c47eProduct name120190703
0e579b5c-f0b5-e690-466e-4a5e809e2c68Product name320190627
6f122144-2ceb-48fa-a906-0d2eb742717eProduct name120190624
8051c8a3-aee0-45a2-a236-8ee3f9e65f67Product name120181211
fbdbfbef-2c33-0298-4fef-f6693e670fe1Product name720181210
d07e0b9e-e041-41dc-942a-a2a6601dc221Product name120181029
af19b329-4f44-cd81-491a-fbb7fe7a079fProduct name220151013
c873f14e-2add-4d53-b9b3-bf775efd3702Product name120150325
e1098f43-eafb-82a0-ef30-575f1d8189b0Product name220150227
9ceb457b-0c09-9326-bbca-f296202d412cProduct name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
31722-506-05LAMIVUDINE and ZIDOVUDINE500 in 1 BOTTLETABLET, FILM COATED5007
31722-506-60LAMIVUDINE and ZIDOVUDINE60 in 1 BOTTLETABLET, FILM COATED607

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
LAMIVUDINEACTIVE INGREDIENT2T8Q726O95LAMIVUDINE AND ZIDOVUDINE TABLET, FILM COATED [CAMBER PHARMACEUTICALS, INC.]1
ZIDOVUDINEACTIVE INGREDIENT4B9XT59T7SLAMIVUDINE AND ZIDOVUDINE TABLET, FILM COATED [CAMBER PHARMACEUTICALS, INC.]1
LAMIVUDINEACTIVE MOIETY2T8Q726O95LAMIVUDINE AND ZIDOVUDINE TABLET, FILM COATED [CAMBER PHARMACEUTICALS, INC.]1
ZIDOVUDINEACTIVE MOIETY4B9XT59T7SLAMIVUDINE AND ZIDOVUDINE TABLET, FILM COATED [CAMBER PHARMACEUTICALS, INC.]1
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61ULAMIVUDINE AND ZIDOVUDINE TABLET, FILM COATED [CAMBER PHARMACEUTICALS, INC.]1
COLLOIDAL SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4LAMIVUDINE AND ZIDOVUDINE TABLET, FILM COATED [CAMBER PHARMACEUTICALS, INC.]1
HYPROMELLOSESINACTIVE INGREDIENT3NXW29V3WOLAMIVUDINE AND ZIDOVUDINE TABLET, FILM COATED [CAMBER PHARMACEUTICALS, INC.]1
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30LAMIVUDINE AND ZIDOVUDINE TABLET, FILM COATED [CAMBER PHARMACEUTICALS, INC.]1
POLYETHYLENE GLYCOLSINACTIVE INGREDIENT3WJQ0SDW1ALAMIVUDINE AND ZIDOVUDINE TABLET, FILM COATED [CAMBER PHARMACEUTICALS, INC.]1
POLYSORBATE 80INACTIVE INGREDIENT6OZP39ZG8HLAMIVUDINE AND ZIDOVUDINE TABLET, FILM COATED [CAMBER PHARMACEUTICALS, INC.]1
SODIUM STARCH GLYCOLATE TYPE A POTATOINACTIVE INGREDIENT5856J3G2A2LAMIVUDINE AND ZIDOVUDINE TABLET, FILM COATED [CAMBER PHARMACEUTICALS, INC.]1
TITANIUM DIOXIDEINACTIVE INGREDIENT15FIX9V2JPLAMIVUDINE AND ZIDOVUDINE TABLET, FILM COATED [CAMBER PHARMACEUTICALS, INC.]1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
31722-506LAMIVUDINE AND ZIDOVUDINE (LAMIVUDINE AND ZIDOVUDINE) TABLET, FILM COATED [CAMBER PHARMACEUTICALS, INC.]7Current NDC, Legacy NDC, 2 package rows20220919_f80bd0f3-47eb-4b82-a633-4536cf376cf6.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
200082lamiVUDine 150 MG / zidovudine 300 MG Oral TabletPSNff62c5fc-965d-4534-a571-a4f290cb9d8313
200082lamivudine 150 MG / zidovudine 300 MG Oral TabletSCDff62c5fc-965d-4534-a571-a4f290cb9d8313
2000823TC 150 MG / AZT 300 MG Oral TabletSYff62c5fc-965d-4534-a571-a4f290cb9d8313
200082lamiVUDine 150 MG / zidovudine 300 MG Oral TabletPSNf80bd0f3-47eb-4b82-a633-4536cf376cf67
200082lamivudine 150 MG / zidovudine 300 MG Oral TabletSCDf80bd0f3-47eb-4b82-a633-4536cf376cf67
2000823TC 150 MG / AZT 300 MG Oral TabletSYf80bd0f3-47eb-4b82-a633-4536cf376cf67
200082lamiVUDine 150 MG / zidovudine 300 MG Oral TabletPSN005f1b9d-1950-4ef3-a9d6-c428a40a36305
200082lamivudine 150 MG / zidovudine 300 MG Oral TabletSCD005f1b9d-1950-4ef3-a9d6-c428a40a36305
2000823TC 150 MG / AZT 300 MG Oral TabletSY005f1b9d-1950-4ef3-a9d6-c428a40a36305

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
31722-506-0531722050605500 TABLET, FILM COATED in 1 BOTTLE (31722-506-05) 2015-09-180000-00-00NoNoCurrent
31722-506-603172205066060 TABLET, FILM COATED in 1 BOTTLE (31722-506-60) 2015-09-180000-00-00NoNoCurrent